SURFACE TREATMENT OF INFECTION OF THE LUNGS BY RATOGENIC BACTERIA OF ATYPICAL PNEUMONIA

摘要

Infection with pathogenic bacteria of SARS is rampant all over the world and shocking the entire international society, mortality is high and does not decrease, medical circles do not know what to do. Over the past hundred-plus years in medicine, pulmonary infectious diseases are subordinated to the category of diseases of internal tissues, but this invention shows the error of this medical interpretation. Due to the fact that it is necessary to define air as a contact area, an SARS infection is a kind of superficial ulcerative infection. Based on the changes in the above medical interpretation, the optimal therapeutic method was found. It has ceased to be a dream that patients initially infected with the pathogenic bacteria of SARS need only rinse their lungs in a few hours and leave the hospital. The pathogenic bacteria of SARS will no longer be able to threaten life, and humanity can declare victory over them. Surface treatment of lung infection with pathogenic bacteria of SARS is the brainchild of a completely new medical concept, and mono-oxygen therapy is the core of surface treatment. Pour into the lungs a liquid with a dissolved degasser, and this liquid is a liquid for the surface treatment of mono-oxygen therapy. The formal name for this fluid is perfluoride (PFC), and ozone is the sterilizer.